Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “lung cancer”
Sponsor: Peking University Cancer Hospital & Institute
SCLC, Extensive Stage · Immunotherapy · Chemotherapy · Radiotherapy
China
Sponsor: Tubulis GmbH
Ovarian Cancer · Non-small Cell Lung Cancer
United States, Belgium, Germany, Romania, Spain +2 more
Sponsor: Bristol-Myers Squibb
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: NextCure, Inc.
Advanced Solid Tumors · Platinum Resistant Ovarian Cancer · Fallopian Tube Cancer · Renal Cell Carcinoma (RCC)
United States, China
Sponsor: Puma Biotechnology, Inc.
Small Cell Lung Cancer
United States
- A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLCActive Not Recruiting
Sponsor: Amgen
Small Cell Lung Cancer (SCLC)
United States, Argentina, Australia, Belgium, Brazil +11 more
Sponsor: Bezmialem Vakif University
Lung Cancer · Postoperative Pulmonary Complications
Turkey (Türkiye)
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Small-cell Lung Cancer
United States, Austria, Belgium, China, France +8 more
Sponsor: Xiu Huang
Lung Cancer (Diagnosis)Chemotherapy-Induced Nausea and Vomiting
China
Sponsor: Bristol-Myers Squibb
Cervical Cancer · Gastric/Gastroesophageal Junction Adenocarcinoma · Microsatellite Stable Colorectal Cancer · Non-Small-Cell Lung Cancer
United States, Australia, Canada, Germany, Israel +3 more
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Non Small Cell Lung Cancer
France
Sponsor: Cancer Research UK
Haematological Malignancy · Malignant Neoplasm · Lymphoproliferative Disorders · Neoplasms by Histologic Type
United Kingdom
Sponsor: NRG Oncology
Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma · Metastatic Lung Non-Small Cell Carcinoma · Metastatic Malignant Neoplasm in the Leptomeninges
United States
- BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)Recruiting
Sponsor: SCRI Development Innovations, LLC
Limited Stage Small Cell Lung Cancer
United States
Sponsor: University of Texas Southwestern Medical Center
Small Cell Lung Cancer Extensive Stage · Brain Metastases · Solid Tumor, Adult · Thoracic Cancer
United States
Sponsor: Hoffmann-La Roche
Lung Cancer, Hepatocellular Carcinoma
Austria, Belgium, Bulgaria, Italy, Poland +3 more
Sponsor: NRG Oncology
Locally Advanced Lung Non-Small Cell Carcinoma · Stage IIB Lung Cancer AJCC v8 · Stage III Lung Cancer AJCC v8
United States, Canada
Sponsor: Rigshospitalet, Denmark
Carcinoma, Non-Small-Cell Lung
Denmark
Sponsor: Pfizer
Small Cell Lung Cancer (SCLC)
United States, Australia, China, France, Germany +5 more
Sponsor: Pfizer
Non-small Cell Carcinoma · Non-Small Cell Lung Cancer Metastatic · Non-Small Cell Lung Carcinoma
United States, Argentina, Australia, Belgium, Brazil +24 more
Sponsor: Shengjing Hospital
Hepatocellular Carcinoma (HCC) · Intrahepatic Cholangiocarcinoma (Icc) · Hepatic Metastasis · Hepatic Hemangioma
China
Sponsor: Ohio State University Comprehensive Cancer Center
Lung Cancer · Breast Cancer · Prostate Cancer · Multiple Myeloma
United States
- An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibActive Not Recruiting
Sponsor: Incyte Corporation
Pancreatic Cancer · Colorectal Cancer (CRC) · Breast Cancer · Lung Cancer
United States, Poland
Sponsor: National Cancer Institute (NCI)
Multiple Myeloma · Lymphoma, Non-Hodgkin · Leukemia-Lymphoma, Adult T-Cell · Hodgkin Disease
United States
Sponsor: National Cancer Institute (NCI)
Urethral Neoplasms · Neoplasms, Urethral · Cancer of the Urethra · Urethral Cancer
United States